EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering the Effects and Molecular Mechanisms of Shaoyao Decoction Against Colorectal Cancer Using Network Pharmacology Analysis Coupled With Experimental Validation and Gut Microbiota Analysis

Yaojun Rong, Guiyu Zhang, Wenhao Ye, Linhua Qi, Xiaojiang Hao, Xiaolin Li, Wuhong Zhang, Yangfa Chao, Shaodong Gu iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yaojun Rong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colorectal Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 High-quality Development Research Project of Shenzhen Bao'an Public Hospital, The Basic Research Project of Bao'an District, Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic gut inflammation and dysbiosis contribute significantly to colorectal cancer (CRC) development. Shaoyao decoction (SYD) is a well‐established Chinese medicine prescription. Besides ameliorating CRC via anti‐inflammatory effects, SYD modulates gut microbiota (GM) to improve inflammatory responses in ulcerative colitis (UC). However, whether and how SYD suppresses CRC by regulating GM remains largely unknown.

Methods

SD rats were orally administered SYD for 7 days to obtain medicated serum. We utilized liquid chromatography–mass spectrometry (LC–MS) analysis, GeneCards, DisGeNET, and SwissTargetPrediction databases to analyze blank and SYD‐medicated rat serum, comparing the findings with those of SYD aqueous extract in previous studies to identify SYD circulating compounds/components with predictable target genes. Using network pharmacology, the potential active compounds and corresponding hub genes associated with modulating GM to suppress CRC were selected for molecular docking. In vivo experiments, a CRC transplantation tumor model was established in BALB/c mice using CT26 cells, with SYD gavage for 14 days. To investigate the mechanism of SYD‐regulated GM against CRC, HE and IHC staining, Western blotting, and 16S rRNA sequencing were employed.

Results

LC–MS identified 26 SYD compounds with computationally predicted target genes. Network pharmacology prioritized 13 compounds targeting 8 inflammation/immunity‐related genes (IL‐17/TNF pathways), validated by molecular docking. In vivo experiments, SYD dose‐dependently suppressed tumor growth ( p < 0.05, medium/high doses), as confirmed by HE staining and IHC analysis of Ki‐67. Notably, SYD potentially delayed CRC liver metastasis and alleviated hepatic injury in tumor‐bearing mice. Western blotting demonstrated SYD's inhibition of the IL‐17/TNF/NF‐κB axis, aligning with computational predictions. 16S rRNA sequencing revealed SYD‐enriched Akkermansia and GM structural shifts, mechanistically linking microbiota remodeling to anti‐tumor efficacy.

Conclusions

SYD combats CRC via dual modulation of IL‐17/TNF/NF‐κB signaling and GM ecosystems (e.g., Akkermansia enrichment). This microbiota‐immune crosstalk positions SYD as a potential adjunct to conventional therapies, particularly for CRC patients with dysbiosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColorectal NeoplasmsDrugs, Chinese HerbalAnimalsNetwork PharmacologyRatsMiceRats, Sprague-DawleyMolecular Docking SimulationMaleHumansMice, Inbred BALB CCell Line, TumorXenograft Model Antitumor Assays

Stichwörter der Autor:innen

16S rRNA sequencingShaoyao decoctioncolorectal cancergut microbiotaliquid chromatography–mass spectrometry (LC–MS)network pharmacology

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.

ORCID-Profile: Shaodong Gu

Förderung

  • 2024 High-quality Development Research Project of Shenzhen Bao'an Public Hospital
  • The Basic Research Project of Bao'an District, Shenzhen

Zitieren

APA

Rong, Y., Zhang, G., Ye, W., Qi, L., Hao, X., Li, X., Zhang, W., Chao, Y., & Gu, S. (2025). Uncovering the Effects and Molecular Mechanisms of Shaoyao Decoction Against Colorectal Cancer Using Network Pharmacology Analysis Coupled With Experimental Validation and Gut Microbiota Analysis. Cancer Medicine. https://doi.org/10.1002/cam4.70813

Vancouver

Rong Y, Zhang G, Ye W, Qi L, Hao X, Li X, et al. Uncovering the Effects and Molecular Mechanisms of Shaoyao Decoction Against Colorectal Cancer Using Network Pharmacology Analysis Coupled With Experimental Validation and Gut Microbiota Analysis. Cancer Medicine. 2025. doi:10.1002/cam4.70813

BibTeX
@article{Rong2025,
  author = {Rong, Yaojun and Zhang, Guiyu and Ye, Wenhao and Qi, Linhua and Hao, Xiaojiang and Li, Xiaolin and Zhang, Wuhong and Chao, Yangfa and Gu, Shaodong},
  title = {Uncovering the Effects and Molecular Mechanisms of Shaoyao Decoction Against Colorectal Cancer Using Network Pharmacology Analysis Coupled With Experimental Validation and Gut Microbiota Analysis},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70813}
}
Kostenlos starten →